All three orforglipron groups had significantly greater improvements in multiple cardiometabolic risk factors than placebo, including waist circumference, fasting serum glucose, systolic blood pressure, lipids and high-sensitivity C-reactive protein
Nausea Diarrhea Vomiting Constipation Dysesthesia (skin sensations) Stomach pain Headache Fatigue Upset stomach Dizziness Bloating Belching Low blood sugar in patients with type 2 diabetes Flatulence Gastroenteritis Heartburn Hair loss You are encouraged to report negative side effects of prescription products: Contact Novo Nordisk Inc
Wu SX, Zhao XY, Yang YH, Zhou MQ, Zheng Y, Wu ZJ, Zou QY, Zhang TT, Du L
What are best supplements for Keratosis Pilaris
DHHB (Dihydrohonokiol-B) is an oral supplement derived from magnolia bark with neuroprotective and anxiolytic properties